Jane P. Richards

2.2k total citations · 1 hit paper
23 papers, 1.9k citations indexed

About

Jane P. Richards is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Jane P. Richards has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Biochemistry. Recurrent topics in Jane P. Richards's work include Nitric Oxide and Endothelin Effects (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and T-cell and Retrovirus Studies (2 papers). Jane P. Richards is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and T-cell and Retrovirus Studies (2 papers). Jane P. Richards collaborates with scholars based in United States, Russia and Italy. Jane P. Richards's co-authors include Richard G. Brennan, Richard H. Goodman, Hans Peter Bächinger, Roland P.S. Kwok, James R. Lundblad, M R Green, Stefan G. E. Roberts, John C. Chrivia, Gary J. Rosenthal and Xicheng Sun and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jane P. Richards

23 papers receiving 1.8k citations

Hit Papers

Nuclear protein CBP is a coactivator for the transcriptio... 1994 2026 2004 2015 1994 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane P. Richards United States 13 1.2k 409 322 236 214 23 1.9k
Valya Russanova Bulgaria 15 2.8k 2.4× 745 1.8× 367 1.1× 188 0.8× 485 2.3× 26 3.5k
Giovanni Perini Italy 33 2.4k 2.1× 427 1.0× 217 0.7× 176 0.7× 425 2.0× 69 3.3k
Cory Abate United States 16 2.0k 1.7× 335 0.8× 283 0.9× 347 1.5× 185 0.9× 16 2.7k
Joan Bertran Spain 23 1.0k 0.9× 238 0.6× 217 0.7× 263 1.1× 372 1.7× 41 2.4k
Yuanzheng He China 21 925 0.8× 278 0.7× 121 0.4× 265 1.1× 102 0.5× 43 1.8k
Wayne V. Vedeckis United States 27 994 0.8× 939 2.3× 307 1.0× 486 2.1× 293 1.4× 54 2.1k
Chong‐Feng Xu United States 27 1.9k 1.6× 206 0.5× 394 1.2× 339 1.4× 368 1.7× 53 2.8k
C Abate United States 18 1.8k 1.5× 360 0.9× 210 0.7× 239 1.0× 342 1.6× 19 2.3k
Xiang-Jiao Yang Canada 24 3.8k 3.2× 710 1.7× 245 0.8× 220 0.9× 621 2.9× 32 4.2k
Anthony Rossomando United States 24 2.2k 1.8× 205 0.5× 318 1.0× 382 1.6× 332 1.6× 39 2.9k

Countries citing papers authored by Jane P. Richards

Since Specialization
Citations

This map shows the geographic impact of Jane P. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane P. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane P. Richards more than expected).

Fields of papers citing papers by Jane P. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane P. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane P. Richards. The network helps show where Jane P. Richards may publish in the future.

Co-authorship network of co-authors of Jane P. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Jane P. Richards. A scholar is included among the top collaborators of Jane P. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane P. Richards. Jane P. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Mutka, Sarah C., Xicheng Sun, Jian Qiu, et al.. (2014). Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation. BMC Pulmonary Medicine. 14(1). 3–3. 42 indexed citations
4.
Sun, Xicheng, Jian Qiu, Louis S. Green, et al.. (2012). Structure–activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: Carboxamide modification. Bioorganic & Medicinal Chemistry Letters. 22(6). 2338–2342. 12 indexed citations
5.
Mutka, Sarah C., et al.. (2012). ADH IB Expression, but Not ADH III, Is Decreased in Human Lung Cancer. PLoS ONE. 7(12). e52995–e52995. 9 indexed citations
6.
Sun, Xicheng, Jian Qiu, Louis S. Green, et al.. (2011). Structure–activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: Pyrrole regioisomers and propionic acid replacement. Bioorganic & Medicinal Chemistry Letters. 21(12). 3671–3675. 15 indexed citations
7.
Sun, Xicheng, Jian Qiu, Louis S. Green, et al.. (2011). Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities. Bioorganic & Medicinal Chemistry Letters. 21(19). 5849–5853. 22 indexed citations
8.
Sun, Xicheng, Jan W. F. Wasley, Jian Qiu, et al.. (2011). Discovery of S-Nitrosoglutathione Reductase Inhibitors: Potential Agents for the Treatment of Asthma and Other Inflammatory Diseases. ACS Medicinal Chemistry Letters. 2(5). 402–406. 46 indexed citations
9.
Damaj, Bassam B., et al.. (2009). A Novel Compound That Inhibits S-Nitrosoglutathione Reductase Protects A gainst Experimental Asthma.. A4151–A4151. 2 indexed citations
10.
Richards, Jane P., Mary P. Stickelmeyer, Bruce H. Frank, et al.. (1999). Preparation of a microcrystalline suspension formulation of LysB28ProB29‐human insulin with ultralente properties. Journal of Pharmaceutical Sciences. 88(9). 861–867. 6 indexed citations
11.
Richards, Jane P., Mary P. Stickelmeyer, David B. Flora, et al.. (1998). Self-Association Properties of Monomeric Insulin Analogs Under Formulation Conditions. Pharmaceutical Research. 15(9). 1434–1441. 28 indexed citations
12.
Lundblad, James R., Roland P.S. Kwok, Megan E. Laurance, et al.. (1998). The Human T-cell Leukemia Virus-1 Transcriptional Activator Tax Enhances cAMP-responsive Element-binding Protein (CREB) Binding Activity through Interactions with the DNA Minor Groove. Journal of Biological Chemistry. 273(30). 19251–19259. 63 indexed citations
13.
Laurance, Megan E., Roland P.S. Kwok, Mary Huang, et al.. (1997). Differential Activation of Viral and Cellular Promoters by Human T-cell Lymphotropic Virus-1 Tax and cAMP-responsive Element Modulator Isoforms. Journal of Biological Chemistry. 272(5). 2646–2651. 41 indexed citations
14.
Richards, Jane P.. (1997). Evidence based general practice. BMJ. 314(7079). 525–525. 7 indexed citations
15.
Richards, Jane P., Hans Peter Bächinger, Richard H. Goodman, & Richard G. Brennan. (1996). Analysis of the Structural Properties of cAMP-responsive Element-binding Protein (CREB) and Phosphorylated CREB. Journal of Biological Chemistry. 271(23). 13716–13723. 108 indexed citations
16.
Kwok, Roland P.S., James R. Lundblad, John C. Chrivia, et al.. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370(6486). 223–226. 1270 indexed citations breakdown →
17.
Wilkinson, Miles, Jeanine Kleeman, Jane P. Richards, & Carol L. MacLeod. (1990). A novel oncofetal gene is expressed in a stage-specific manner in murine embryonic development. Developmental Biology. 141(2). 451–455. 62 indexed citations
18.
Richards, Jane P.. (1988). MEDICINE AND LABOUR: The politics of a profession. Europe PMC (PubMed Central). 38(306). 39–39. 6 indexed citations
19.
Richards, Jane P.. (1980). WHY SUFFER? PERIODS AND THEIR PROBLEMS. Journal of the Royal College of General Practitioners. 30(216). 443–443. 1 indexed citations
20.
Richards, Jane P.. (1979). LEGAL AND ETHICAL ISSUES IN HUMAN RESEARCH AND TREATMENT — PSYCHOPHARMACOLOGIC CONSIDERATIONS. PubMed Central. 29(207). 626–626. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026